Evidence map›Paper›PMID 38407780›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2024

Canine parvovirus type 2 (CPV-2) serological and molecular patterns in dogs with viral gastroenteritis from southern Brazil.

Lotta Henni Truyen, Rafael Sartori Flores, Weslei de Oliveira Santana, Muriel Becker Abreu, Gustavo Brambatti, Vagner Ricardo Lunge, André Felipe Streck

Open access · greenAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. CRISPR/Cas system and its application in the diagnosis of animal infectious diseases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Review
  3. In silico designing of multi-epitope vaccine against canine parvovirus using reverse vaccinology.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Lotta Henni TruyenUniversity of Veterinary Medicine Hannover, Hannover, Germany.
Rafael Sartori FloresDiagnostic Laboratory of Veterinary Medicine, Biotechnology Institute, Universidade de Caxias Do Sul (UCS), Caxias Do Sul, Rio Grande Do Sul, Brazil.
Weslei de Oliveira SantanaDiagnostic Laboratory of Veterinary Medicine, Biotechnology Institute, Universidade de Caxias Do Sul (UCS), Caxias Do Sul, Rio Grande Do Sul, Brazil.
Muriel Becker AbreuDiagnostic Laboratory of Veterinary Medicine, Biotechnology Institute, Universidade de Caxias Do Sul (UCS), Caxias Do Sul, Rio Grande Do Sul, Brazil.
Gustavo BrambattiDiagnostic Laboratory of Veterinary Medicine, Biotechnology Institute, Universidade de Caxias Do Sul (UCS), Caxias Do Sul, Rio Grande Do Sul, Brazil.
Vagner Ricardo LungeDiagnostic Laboratory of Veterinary Medicine, Biotechnology Institute, Universidade de Caxias Do Sul (UCS), Caxias Do Sul, Rio Grande Do Sul, Brazil.
André Felipe StreckDiagnostic Laboratory of Veterinary Medicine, Biotechnology Institute, Universidade de Caxias Do Sul (UCS), Caxias Do Sul, Rio Grande Do Sul, Brazil. afstreck@ucs.br.ORCID http://orcid.org/0000-0002-4798-0777
Universidade de Caxias do Sul · BRUniversity of Veterinary Medicine Hannover, Foundation · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canine Parvovirus type 2 (CPV-2) is a highly contagious virus that can cause severe systemic disease with gastroenteric symptoms in dogs, particularly in young puppies. Originating from the feline parvovirus in the late 1970s, it swiftly propagated globally, instigating a pandemic in dogs. Despite vaccination advancements, CPV-2 remains a substantial challenge for veterinary professionals and pet owners. This study aimed to contribute knowledge about the current situation of CPV-2 among dogs in southern Brazil. In this study, the sera of 125 dogs (mostly with gastroenteritis symptoms) were screened for antibodies against CPV-2 and their faeces for the virus itself. The results showed that 40% (50/125) of dogs were infected with CPV-2. Most animals (65.5%) had previously been exposed to CPV-2 (with serotitres equal or above 1:40), and only 37.6% had protective antibody titres equal or above 1:80. The findings have also demonstrated that vaccination against CPV-2 significantly reduced the risk of infection, with positive cases decreasing from 56.9% (unvaccinated) to 2.0% (fully vaccinated). Furthermore, the prevalence of CPV-2 decreased as dogs aged, with younger dogs and those with an incomplete or non-existent vaccination history at the highest risk of infection. In conclusion, this study provides valuable insight into the prevalence and risk factors associated with CPV-2 infection in dogs in southern Brazil, thereby providing valuable knowledge for the improvement of veterinary care and pet health.

Indexed as

Antibodies, ViralDog DiseasesGastroenteritisParvoviridae InfectionsParvovirus, CanineAnimalsBrazilDogsFecesFemaleMaleVaccinationAntibodies, ViralBrazilCanine ParvovirusCPV-2DogsPrevalenceSerotitres

Identifiers

PMID38407780
PMCPMC11153423
OpenAlexW4392165164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.